Phase II trial of dendritic cell vaccine-Immunicum (INTUVAX)

Trial Profile

Phase II trial of dendritic cell vaccine-Immunicum (INTUVAX)

Phase of Trial: Phase II

Latest Information Update: 19 Feb 2014

At a glance

  • Drugs Ilixadencel (Primary)
  • Indications Renal cell carcinoma
  • Focus Therapeutic Use
  • Sponsors Immunicum
  • Most Recent Events

    • 19 Feb 2014 New trial record
    • 05 Dec 2013 Immunicum is expecting to initiate this trial in 2014, according to a media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top